We are live on
!
Find out more
Anika Therapeutics
ANIK
ANIK
122 hedge funds and large institutions have $335M invested in Anika Therapeutics in 2022 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 49 increasing their positions, 40 reducing their positions, and 15 closing their positions.
New
Increased
Maintained
Reduced
Closed
358% more call options, than puts
Call options by funds: $1.97M | Put options by funds: $431K
23% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 40
11% more capital invested
Capital invested by funds: $302M → $335M (+$33M)
3.34% more ownership
Funds ownership: 93.11% → 96.45% (+3.3%)
3% less funds holding
Funds holding: 126 → 122 (-4)
27% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 15
Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.1%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
49
Reduced
40
Closed
15
Calls
$1.97M
Puts
$431K
Net Calls
+$1.54M
Net Calls Change
+$1.52M
Top Buyers
| 1 |
Janus Henderson Group
London,
United Kingdom
|
+$12.6M |
| 2 |
TI
Trigran Investments
Northbrook,
Illinois
|
+$7.78M |
| 3 |
BFM
Boothbay Fund Management
New York
|
+$3.91M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$2.59M |
| 5 |
State Street
Boston,
Massachusetts
|
+$1.18M |
